|
|
DSpace at RU >
Browsing by Author Lems, W.F.
Showing results 1 to 9 of 9
| Full Text | Issue Date | Title | Author(s) | | 2012 | Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis. | Lent, P.L.E.M. van; Blom, A.B.; Schelbergen, R.F.P., et al |
| 2007 | [Alendronate more effective than alfacalcidol in the prevention of osteoporosis in patients with rheumatic disease who are starting glucocorticoid therapy] | Nijs, R.N. de; Jacobs, J.W.; Lems, W.F., et al |
| 2006 | Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis. | Nijs, R.N. de; Jacobs, J.W.; Lems, W.F., et al |
| 2012 | Esomeprazole relieves upper gastrointestinal symptoms in high-risk and average-risk NSAID users in daily clinical practice: results from an open-label study. | Tielemans, M.M.; Oijen, M.G.H. van; Mulder, C.J., et al |
| 2004 | Long term high intensity exercise and damage of small joints in rheumatoid arthritis. | Jong, Z. de; Munneke, M.; Zwinderman, A.H., et al |
| 2007 | Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis. | Jacobs, J.W.; Nijs, R.N. de; Lems, W.F., et al |
| 2009 | Richtlijn ‘Diagnostiek en behandeling van reumatoïde artritis’ | Schipper, L.G.; Hoekstra, M.O.; Vliet Vlieland, T.P.M., et al |
| 2004 | Slowing of bone loss in patients with rheumatoid arthritis by long-term high-intensity exercise: results of a randomized, controlled trial. | Jong, Z. de; Munneke, M.; Lems, W.F., et al |
| 2008 | Value of serum cartilage oligomeric matrix protein as a prognostic marker of large-joint damage in rheumatoid arthritis--data from the RAPIT study. | Jong, Z de; Munneke, M.; Vilim, V., et al |
Showing results 1 to 9 of 9
|